The University of Birmingham will be delivering on-site courses on advanced therapy medicinal products (ATMPs) manufacturing and clinical adoption. These include modules on ATMP manufacturing design and clinical adoption, as well as documentation and implementation of ATMPs, which will be delivered as a combination of on-site, online learning and virtual reality modules.
First course will be launched on September 2021 covering ATMPs and Good Manufacturing Practice (GMP) as well as master’s degree level modules on GMP standards, which are a vital requirement for the authorisation, manufacture, and commercialisation of ATMPs.
The National Training Centres are a part of the ATSTN initiative, which also includes an Online Training Platform to provide remote learning for those currently working in the vaccine manufacturing and advanced therapy industry, and a Career Converter, which maps an individual's transferrable skills from adjacent sectors into recommended roles for this industry.
If you are unsure which course to take or need more information about any of the courses available at our National Training Centres, please get in touch with us and we will be more than happy to discuss this with you.